A patient whose malignant clone is positive for the CD markers CD15 and CD30 is most likely to have what clinical disease?

Question

Quizplus · Accepted Answer

CD15 and CD30 are typically expressed by Reed-Sternberg cells in Hodgkin lymphoma, making it the most likely clinical diagnosis for a patient with a malignant clone positive for these markers. Negative for CD marker CD20 eliminates Non-Hodgkin lymphoma as a possibility. CD markers specific to acute lymphocytic leukemia and hairy-cell leukemia are not mentioned.

A Patient Whose Malignant Clone Is Positive for the CD